CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

Showing 4 of 4 entries

View as:

Phase: N/A Priority: Normal

NCT ID: NCT03735680 Org: User:

Start: 08/09/19 End: 11/18/21 Due: 11/18/22

Phase: N/A Priority: Normal

NCT ID: NCT06022029 Org: User:

Start: 10/13/23 End: 08/29/26 Due: 08/29/27

Phase: N/A Priority: Normal

NCT ID: NCT04950166 Org: User:

Start: 11/30/21 End: 01/20/23 Due: 01/20/24

Phase: N/A Priority: Normal

NCT ID: NCT05048082 Org: User:

Start: 04/13/22 End: 08/31/22 Due: 08/31/23

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer	NCT03735680	OncoNano Medicine, Inc.	user2@example.com	None	2019-08-09	2021-11-18	2022-11-18	-	-	2025-07-14
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.	NCT06022029	OncoNano Medicine, Inc.	user2@example.com	None	2023-10-13	2026-08-29	2027-08-29	-	-	2025-07-14
A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri Mets	NCT04950166	OncoNano Medicine, Inc.	user2@example.com	None	2021-11-30	2023-01-20	2024-01-20	-	-	2025-07-14
A Study to Evaluate Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung Malignancies	NCT05048082	OncoNano Medicine, Inc.	user2@example.com	None	2022-04-13	2022-08-31	2023-08-31	-	-	2025-07-14